CNS Pharmaceuticals, Inc. (CNSP)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+13.58% vs
Rating Accuracy
50.0% (1 of 2*)
FV Performance
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+259.3%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+131.73%
FV Accuracy
7 Hits (14.29% Hit Rate)
FV Avg. Distance
+101.39%
About
CEO
John M. Climaco
Employees
5
Industry
-
Sector
-
Headquarters
Houston
Exchange
NASDAQ
Website
http://www.cnspharma.comSummary Stats
Market Cap
11.1M
Revenue
-
Net Income
-
EPS
$0.00
Price-to-Earnings
-
Price-to-Book
-
Debt-to-Equity
-
News
Analyst Ratings
Price targets projected by 2 analysts
High
$11.00
Average
$9.50
Low
$8.00
Ratings calculated by 1 analyst
Buy
1
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q1 2022
Above by $0.04
-$0.07 +36.4%
-0.11
-0.15
Up 53%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--